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GAFCHROMIC EBT2 film measurements. Dependence in the response of the MOSkin detector on the
surface of solid water phantom was also tested for different (i) source to surface distances (SSDs); (ii)
field sizes; (iii) surface dose; (iv) radiation incident angles; and (v) wedges. The MOSkin detector showed
excellent reproducibility and linearity for dose range of 50 cGy to 300 cGy. The MOSkin detector showed
reliable response to different SSDs, field sizes, surface, radiation incident angles, and wedges. The
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In vivo dosimetry is important during radiotherapy to ensure the accuracy of the
dose delivered to the treatment volume. A dosimeter should be characterized
based on its application before it is used for in vivo dosimetry. In this study, we
characterize a new MOSFET-based detector, the MOSkin detector, on surface
for in vivo skin dosimetry. The advantages of the MOSkin detector are its water
equivalent depth of measurement of 0.07 mm, small physical size with submicron dosimetric volume, and the ability to provide real-time readout. A MOSkin
detector was calibrated and the reproducibility, linearity, and response over a
large dose range to different threshold voltages were determined. Surface dose
on solid water phantom was measured using MOSkin detector and compared
with Markus ionization chamber and GAFCHROMIC EBT2 film measurements.
Dependence in the response of the MOSkin detector on the surface of solid water
phantom was also tested for different (i) source to surface distances (SSDs);
(ii) field sizes; (iii) surface dose; (iv) radiation incident angles; and (v) wedges.
The MOSkin detector showed excellent reproducibility and linearity for dose range
of 50 cGy to 300 cGy. The MOSkin detector showed reliable response to different
SSDs, field sizes, surface, radiation incident angles, and wedges. The MOSkin
detector is suitable for in vivo skin dosimetry.
PACS number: 87.55.Qr
Key words: MOSFET, in vivo dosimetry, surface dose, skin dose, characterization,
quality assurance (QA)
I.

Introduction

Quality assurance (QA) in radiotherapy is very important in order to ensure the correct functioning of all components in radiotherapy, from treatment planning to the delivery of the treatment.(1)
Nowadays, advanced radiotherapy techniques, such as intensity-modulated radiotherapy (IMRT),
require patient-specific QA to be performed to ensure the accuracy of radiation delivery during
radiotherapy. However, these QA and verification procedures may not be sufficient to ensure
the accuracy of the entire radiotherapy treatment.
A number of incidents have been reported recently.(2-4) Human errors and systematic errors
contributed to these incidents. Therefore, towards that end, in vivo dosimetry can detect
major errors during the delivery of radiotherapy. It also can access clinical relevant differences between planned and delivered dose, record the dose received by the patient, and fulfill
legal requirements.(1)
a
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In radiotherapy, in vivo dosimetry means the measurement of the radiation dose received by
a patient during treatment.(1) Ideally, a dosimeter should be positioned at the point of interest
inside a patient’s body. However, in many cases it is not possible to place a dosimeter inside
a real patient’s body. Hence, the placement of a dosimeter on the surface of the patient’s body
becomes an alternative.
An ideal in vivo dosimeter should possess the following characteristics: (i) tissue equivalent;
(ii) small in physical size and has small sensitive volume; (iii) features (e.g., temperature, energy)
which are consistent and characterizable; (iv) does not perturb the radiation field; (v) nonhazardous to humans; and (vi) able to provide real-time dosimetric information. Thermoluminescence
dosimeter (TLD)(5-7) is small in size, but requires a long series of pre- and postirradiation
process. Radiochromic film(8-10) has excellent dosimetric spatial resolution, is able to provide
two-dimensional (2D) dosimetric information(11) and is easy to use, but it is not done in real-time
and may be affected by improper handling and scanner performance. Semiconductor detectors such as diode(12-13) and metal oxide semiconductor field effect transistor (MOSFET)(14-19)
are able to achieve excellent spatial resolution with their small sensitive volumes. However,
the energy, angle, temperature, and dose-rate dependence of semiconductor detectors require
rigorous characterization.
The dose deposited on a phantom or patient surface mainly comes from primary photon
beam, backscattered radiation from the phantom, as well as radiation contamination from the
accelerator. Radiation contamination arises from: (i) treatment head materials and (ii) treatment
setup parameters such as source-to-surface distance (SSD), field size, and beam modifier to the
surface dose.(20) These contaminations will affect the dose in the buildup region. Therefore, it
is essential to determine and know the effect of these treatment parameters.
Different terminologies, such as surface dose, skin dose, and entrance dose, have been used
to describe the dose measured on the surface of a phantom or a human. The definitions for these
terminologies differ according to the point of measurement on the patient or phantom. Surface
dose is defined as the dose on the surface of the phantom or human, which is the interface between
the air and the surface. Skin dose is defined as the dose at the depth of 0.07 mm.(21) Entrance
dose is defined as the dose given by the entrance beam at the depth of maximum dose.(22)
Characterization of a dosimeter is normally performed at a condition where charged particle
equilibrium (CPE) condition exists.(12-13,19) However, for in vivo skin dosimetry, the dosimeter
should be characterized on the surface instead of the depth of maximum dose. This is because
the dosimetric condition of skin surface and buildup region is different from the dosimetric
condition at the depth of maximum dose. At the interface of two media (air and human tissue),
CPE does not exist and there is a steep dose gradient in the buildup region. Therefore, characterization of a dosimeter on surface is needed prior to using it for in vivo skin dosimetry.
A MOSFET-based dosimeter, the MOSkin detector was designed and prototyped by the
Center for Medical Radiation Physics (CMRP) in the University of Wollongong (UoW). The
advantages of the MOSkin detector, such as being small in size with submicron dosimetric
volume which provides excellent dosimetry spatial resolution, as well as the ability to provide
real-time reading and instant readout, make it suitable for in vivo skin dosimetry measurement.
The MOSkin detector has been characterized and been used for dose measurement in megavoltage radiotherapy and brachytherapy.(23-30)
In this paper, a full characterization of the MOSkin detector on the surface of a phantom
simulating the actual condition for in vivo skin dosimetry (where non-CPE condition exist)
was performed and reported. These include: (i) detector calibration, linearity, reproducibility;
(ii) source to surface distance dependence; (iii) field size dependence; (iv) surface dose measurement; (v) angular dependence; and (vi) wedge response. Comparison and verifications
were made with previous works with some extension, while benchmarking against different
dosimeters that are available commercially and used extensively in radiotherapy centers.
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II. Materials and Methods
A. 	The MOSkin detector
The MOSkin system is shown in Fig. 1. The MOSkin detector is composed of hermetically sealed
MOSFET dye with submicron thickness of the sensitive volume into Kapton pigtail strip with
thickness of 0.55 mm using “drop-in” packaging technology(31) (Fig. 1(a)). The thin reproducible
polyamide film acts as an electrical connection and buildup for MOSkin, and gives a waterequivalent depth (WED) of approximately 0.07 mm in tissue, making it a suitable dosimeter
for skin dose measurement.(24) According to the International Commission on Radiological
Protection (ICRP) publication,(21) the most radiosensitive layer of epidermis is located at tissue
depth of approximately 0.07 mm. A detailed description of the MOSkin dosimetry system can
be found in Kwan et al.(24) and Qi et al.(26) The readout process of MOSkin detector requires
measurement of the voltage across the gate of the MOSkin detector under condition of the
constant source–drain current that is called the threshold voltage, Vth. The Vth increases with
accumulated radiation dose. The readout current corresponds to the thermostable point of the
MOSFET to avoid errors associated with thermal instability of the Vth. The sensitivity of the
MOSkin detector is defined as the shift of the Vth with the absorption of 1 cGy of radiation
dose (Eq. (1)). In this work, the MOSkin measurements were benchmarked against Markus
ionization chamber (Markus type 23343 parallel plate ionization chamber; PTW, Freiburg,
Germany) and/or GAFCHROMIC EBT2 film (International Specialty Products, Wayne, NJ).
All measurements were carried out three times and the mean ± 1 SD of the readings were
reported unless stated otherwise.
(1)
where ΔVth is the change of the threshold voltage in unit Volt (V).

Fig. 1. MOSkin system, MOSkin detector (top right), and the schematic diagram of MOSkin detector in (a) face-up and
(b) face-down orientation.
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B. GAFCHROMIC EBT2 film preparation
GAFCHROMIC EBT2 films were cut into sizes of 1.5 × 1.5 cm². They were scanned using a
flatbed scanner (Epson 10000XL scanner; Epson America, Inc. Long Beach, CA) 24 hours after
irradiation to allow for postirradiation color changes.(32) The films were scanned in a reflection
mode, at a resolution of 96 dots per inch (dpi), 48-bits RGB format, and analyzed using ImageJ
1.46r software (National Institute of Health, Bethesda, MD). Care was taken to scan the films at
the center of the scanner to avoid scanner-induced nonuniformity. The films were also scanned
in the same orientation to avoid film-induced changes in pixel values.(33) Only the red channel
was used for analysis. A region of interest (ROI) was selected at the center of the film. A set of
standard films was irradiated to establish the calibration curve.
C. 	Detector characterization
C.1 Calibration, linearity, and reproducibility
The MOSkin detectors were calibrated under a Varian Clinac 2100 C/D accelerator (Varian
Medical System, Palo Alto, CA) using 6 MV photon beam under standard conditions (1.5 cm
depth in 30 × 30 × 15 cm³ solid water phantom, 100 cm source–surface distance (SSD), and
10 × 10 cm² field size). Sensitivities of the MOSkin detector have been determined. Linearity
measurement of the MOSkin detector was determined for a dose range of 50 cGy to 300 cGy,
with an increment of 50 cGy, and the reproducibility was assessed.
In this work, the buildup cap for the Markus ionization chamber was removed in order to
position the chamber’s effective measurement closer to the surface. Temperature and pressure
correction factor, polarity effect correction factor, and ionization recombination correction factor
were taken into account for Markus ionization chamber measurements. Parallel plate ionization
chambers (Markus ionization chamber) are known to overrespond due to side scatter from the
chamber’s wall.(34-36) In this work, Gerbi and Khan’s correction(36) (Eqs. (2) and (3)) was only
applied in the surface dose measurement (Material & Methods section C.4).
(2)
(3)
where, P′(d,E) is the corrected PDD, P(d,E) is the measured PDD, E is the energy, l is the plate
separation (2 mm for Markus PTW 23343), α is constant (5.5), C is the sidewall collector distance (0.35 mm for Markus PTW 23343), IR is the ionization ratio, and d is the depth of the
chamber front window below the surface of phantom surface. The calculated ε(d,E) are 10.14
and 6.89 for 6 MV and 10 MV photon beams, respectively.
Except for calibration and dose linearity measurement, all measurements were carried out
on the surface of a solid water phantom. Characterization was carried out using a 30 × 30 × 15
cm³ solid water phantom with a 6 MV photon beam, 100 cm SSD, and 10 × 10 cm² field size
(Fig. 2), unless stated otherwise. This setup is henceforth called the “standard surface setup”.
Cheung et al.(37) has studied the temperature dependence of this MOSFET-based detector.
They reported that this detector shows a variation of 50 mV over the temperature range from
20°–40°C. This variation is corresponding to about 10 cGy in dose. However, in order to get
an accurate reading, the detector should be placed on phantom or patient approximately 60 s
before measurement, to allow thermal equilibrium, and the reading are taken whilst the detector
remains on the phantom or patient. The same precaution was also taken throughout this work
to reduce the effect of temperature dependence of the detector.
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Fig. 2. Schematic diagram of the standard setup of characterization of MOSkin detector on the surface of a solid
water phantom.

C.2 Source-to-surface distance dependence
The MOSkin detector was positioned as per the “standard surface setup”. The response of the
MOSkin detector for different distances from the source was measured with SSD, varying
from 80 cm to 110 cm with 5 cm increments. One hundred MUs were delivered for each and
repeated twice for all measured SSDs. Dose-rate dependence of the MOSkin detector was also
evaluated in this section. The dose rate at dmax was calculated.
C.3 Field size dependence
The MOSkin detector was set up per “standard surface setup” and irradiated with different field
sizes from 1 × 1 cm² to 40 × 40 cm² using 6 MV photon beam.
C.4 Surface dose measurement
The surface dose measured by MOSkin detector for 6 MV and 10 MV photon beams was
evaluated. The measured dose by Markus ionization chamber was corrected, based on Gerbi
and Khan’s formulae.(36)
C.5 Angular dependence
Conventionally, angular dependence of the MOSFET was carried out at a depth where the CPE
condition exists. Kwan et al.(24) and Qi et al.(29) have measured angular dependence of ± 2% for
MOSkin detector in a cylindrical phantom, where the CPE exists, and Qi et al.(26) have measured
angular dependence of 3.1% on the surface of a solid water phantom. As reported in Scalchi
et al.,(17) full buildup setup where CPE exists gives better results than a surface setup.
Here we study the angular response of MOSkin detector placed on the surface of a phantom
as the detector will be used for in vivo skin dose measurement where CPE does not exist. It is
important to note that surface dose increases with beam incidence angle and correct measurements of the surface dose or skin dose for different angles of beam incidence are valuable for
treatment planning system (TPS) verification. In particular, for the case of tangential beams, the
angular response of the MOSkin detector will consist of the increased surface dose due to the
beam incident angle and the intrinsic angular response of the MOSkin. The angular response
of the MOSkin detector was assessed in face-up and face-down orientation, as shown in Figs.
1(a) and (b), by positioning the MOSkin detector per “standard surface setup”. One hundred
Journal of Applied Clinical Medical Physics, Vol. 15, No. 5, 2014

125   Jong et al.: Characterization of MOSkin

125

MUs of 6 MV photon were delivered with the accelerator gantry rotated to the angles of 0° to
75°, with 15° increments.
C.6 Wedge response
In some clinical applications, such as conventional breast radiotherapy, beam modifier devices
like physical wedge (PW) or dynamic wedge (DW)(38-39) may be required to tilt the dose profile,
resulting in an angled isodose curve.(38) Beam quality and dose rate of the incident photons
may change due to the presence of the beam modifier device.(40) For wedge response measurement, the MOSkin detector was irradiated using “standard surface setup”. One hundred MUs
were delivered on the detector in an open field and subsequently with the application of PW
and DW of 15°, 30°, 45°, and 60°.
III.	Results & DISCUSSION
A. Calibration, linearity and reproducibility
The MOSkin detector showed excellent reproducibility with deviation of less than 1% and
excellent linearity (R² = 0.997) for the dose range of 0 cGy to 300 cGy, as shown in Fig. 3. The
reproducibility of the MOSkin detector was determined based on the average standard deviation
(1 SD) of three repeated measurements of each dose level in linearity test. The dose linearity
verification was carried out at this range because it was deemed to be within the range of a
normal fractionated dose in radiotherapy. The average sensitivity of the MOSkin detectors in this
study was 2.53 ± 0.03 mV/cGy for 6 MV photon beam. The sensitivity of the MOSkin detector
as a function of cumulative dose was found to decrease by 9 × 10-2 mV/cGy for every 10 Gy
of delivered dose (Fig. 4). The sensitivity of the MOSkin detectors is expected to decrease as
the cumulative dose increases.(41) Therefore, it is recommended that periodic recalibration be
carried out throughout the detector’s useful lifetime based on the accuracy needed. The readers
are referred to Qi et al.(23) for details of the MOSkin detector’s lifetime.

Fig. 3. Linearity of MOSkin detector for the dose range of 0 cGy to 300 cGy.

Journal of Applied Clinical Medical Physics, Vol. 15, No. 5, 2014

126   Jong et al.: Characterization of MOSkin

126

Fig. 4. Change in sensitivity of MOSkin detector as a function of cumulative dose.

B. Source-to-surface distance dependence
Results of SSD dependence and dose rate dependence measurements for Markus ionization
chamber, GAFCHROMIC EBT2 film, and the MOSkin detector are presented in Fig. 5. All
measured doses were corrected with inverse square correction factor (ISCF) and normalized
to the corrected dose at SSD 100 cm. An ideal SSD independent and dose rate independent
dosimeter will have an “Inverse Square Corrected Relative Dose” equal to one.
From Fig. 5, the MOSkin detector, GAFCHROMIC EBT2 film, and Markus ionization
chamber showed steady response over 80 cm to 110 cm SSD. The average variation of all
SSDs for the MOSkin detector, GAFCHROMIC EBT2 film, and Markus ionization chamber
was 0.1%, 1.0%, and 0.5%, respectively.
On the surface of the phantom, the dose deposited is not only due to the primary beam directed
from the treatment head, but also from the contaminant electrons which are generated outside
of the patient in the air and collimator. This may contribute to the SSD dependence of a skin
dosimeter. This contamination is not sufficient to contribute to SSD dependence for large SSD
as the electrons produced in the accelerator were of relatively high energy.(20) Measurements
at shorter SSD exposed the dosimeter to large amounts of low-energy photons scattered by the
components in the accelerator and would induce a slight over-response of a dosimeter.
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Fig. 5. SSD and dose rate response of Markus ionization chamber, Gafchromic EBT2 film and MOSkin detector corrected with ISCF and normalized to the response at 100 cm SSD. The error bar represents 1 SD of three sets of
measurements.

C. Field size dependence
Qi et al.(26) have also studied the field size dependence of the MOSkin detector on phantom
surface for the field size of 5 × 5 cm2 to 30 × 30 cm2. In this study, the field sizes investigated
were extended to include small field sizes of as small as 1 × 1 cm2 and larger field size of 40 ×
40 cm2. The field size dependence of surface dose measured by MOSkin detector, as well as
EBT2 film and Markus ionization chamber, is shown in Fig. 6. All readings were normalized
to 10 × 10 cm² field size. The three detectors showed an upward trend as field size increases.
This is expected and is due to the increase in the backscattered radiation from the phantom and
radiation contamination. The radiation contamination was mainly due to the scattered radiation from the flattening filter, with a small portion of scattered radiation as a function of field
size.(42) The result of MOSkin detector and Attix ionization chamber from Qi et al.(26) are also
presented in Fig. 6 for comparison. Surface dose increases measured with the MOSkin detectors rose from 0.36 to 2.32 times of the surface dose measurement at 10 × 10 cm² for the field
sizes from 1 × 1 cm² to 40 × 40 cm².
The dose deposited on the surface of the phantom is expected to be only 10%–20% of the
maximum dose (Dmax).(38) As field size increases, the surface dose increases and, hence, there
is a corresponding reduction in the surface dose gradient.(17)
All detectors measured increasing surface dose with increasing field size. For field size < 25 ×
25 cm2, the MOSkin measurements are in good agreement with EBT2 film. MOSkin detector
is advantageous for small field surface dosimetry compared to Markus ionization chamber due
to the small sensitive volume of the detector. For field size > 25 × 25 cm2, MOSkin detector
and Markus ionization chamber measurements showed an enhanced response, compared to the
GAFCHROMIC EBT2 film. This may be due to the side scattering effect of Markus ionization
chamber and energy dependence of the semiconductor (MOSkin) detector.
Good agreement between the MOSkin detector’s response and Attix ionization chamber(29)
(average difference of 2%) has been observed due to close WED of the detectors used. Earlier
reported results of field dependence measured with MOSkin detectors are in agreement (average difference of 3%) with presented results, confirming good reproducibility of WED of the
MOSkin detectors.(26)
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Fig. 6. Field size response of the surface dose measured by MOSkin detector, Gafchromic EBT2 film, and Markus
ionization chamber normalized to response at 10 × 10 cm² radiation field size. The average standard deviation of three
sets of measurements for MOSkin detector, Gafchromic EBT2 film, and Markus ionization chamber is 0.034, 0.052,
and 0.001, respectively.

D. Surface dose measurement
The average sensitivity of the MOSkin detectors was found to be 2.53 ± 0.03 mV/cGy and
2.50 ± 0.02 mV/cGy for 6 MV and 10 MV photon beams, respectively. The MOSkin detectors
were 1.01% more sensitive in 6 MV photon beam compared to 10 MV photon beam.
Table 1 shows the measured surface dose of the MOSkin detector, GAFCHROMIC EBT2
film, and the Markus ionization chamber measurement for 6 MV and 10 MV photon beams.
The surface doses for 6 MV photon measured by these detectors are higher than 10 MV photon
due to the skin sparing effect of 10 MV photon.
Markus ionization chamber measured lowest surface doses for 6 MV and 10 MV photons,
followed by the MOSkin detector and GAFCHROMIC EBT2 film. This can be explained by the
WED of these detectors. Markus ionization chamber was assumed to have WED of 0 mm after
the application of Gerbi and Khan’s correction.(36) MOSkin detector has a WED of 0.070 mm(24)
and GAFCHROMIC EBT2 film has a WED of 0.122 mm. The WED of GAFCHROMIC EBT2
film was determined based on the physical depth and density(43-44) from the surface to the center
of the active layer.
In measuring the surface dose at the depth of 0 cm, the dose difference (%) between the
MOSkin detector and Markus ionization chamber was found to be 4.44% and 1.74% for 6 MV
and 10 MV photon beams, respectively (Table 1). It is expected because the dose gradient in
build-up region for 6 MV photon beam is steeper than that of 10 MV photon beam.
Table 1. Comparison of the surface dose (normalized to 100% the dose at dmax) with Markus ionization chamber,
Gafchromic EBT2 film, and MOSkin detector for 6 MV and 10 MV photons.
Energy
(MV)

Markus
(%)

EBT2
(%)

MOSkin
(%)

6
10

15.83 ± 0.03
11.82 ± 0.00

23.01 ± 0.07
17.89 ± 0.04

20.27 ± 0.03
13.55 ± 0.04
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E. Angular dependence
Figure 7 shows the results of the measured doses which have been normalized to the dose at
0° beam incident angle. The result of MOSkin detector and Attix ionization chamber from Qi
et al.(26) are also presented in Fig. 7 for comparison. As the beam incident angle increases, the
measured surface dose increases because the region of charged particle equilibrium shifts toward
the surface. This is in agreement with the results by Scalchi et al.(17) and Qi et al.(26)
GAFCHROMIC EBT2 film, with its dosimetric properties of tissue equivalence and homogeneous material, is assumed to be of angular independence. Suchowerska et al.(45) reported that
GAFCHROMIC film shows intrinsic angular dependence of less than 1% when a measurement
with the film surface is parallel and perpendicular to the beam direction. MOSkin detector in the
face-up orientation showed similar angular response trend to the GAFCHROMIC EBT2 film
(Fig. 7). GAFCHROMIC EBT2 film measured higher dose as compared to MOSkin detector
in face-up orientation. This may be due to the difference of the WED these detectors (Results
& Discussion section D).
When the MOSkin detector was used in the face-down orientation for surface dose measurement, it showed a trend of overresponse when compared with MOSkin detector and
GAFCHROMIC EBT2 film. Deviation between MOSkin detector in face-up orientation and
face-down orientation is seen to be increasing as the beam incident angle increases. Maximum
deviation of 18.5% was found at beam incident angle of 75°. The observed angular dependence
between MOSkin detector in the face-up orientation and face-down orientation arises from the
effect of the difference in the WED of the detector related to the asymmetric geometry of the
detector (inherent anisotropy). For face-down geometry, the WED is approximately 0.9 mm
due to a 0.4 mm silicon substrate. Therefore, it is very important to identify the orientation of
MOSkin detector when it is used for surface dose measurement. For WED 0.07 mm, MOSkin
detector should be used in a face-up mode. Present result was in good agreement with earlier
reported result(26) with maximum deviation of 2.2 % at angle 30°.

Fig. 7. Relative surface dose measured with Gafchromic EBT2 film and MOSkin detector as the function of beam
incident angle and normalized to 1 at 0° beam incident angle with 10 × 10 cm² field size. The error bar represents 1 SD
of three sets of measurements. The average standard deviation of three sets of measurements for MOSkin detector and
Gafchromic EBT2 film is 0.033 and 0.036, respectively.
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F. Wedge response
The results of the wedge effect are summarized in Fig. 8. The doses were normalized to the
dose measured with open field. The surface dose decreases as the wedge angle increases for
both PW and DW. The average variation of MOSkin measurement with Markus ionization
measurement for PW and DW was -5.5% and 5.1%, respectively. MOSkin measurement is in
close agreement with GAFCHROMIC EBT2 film measurement. GAFCHROMIC EBT2 film
responded higher for PW (2.8%) and DW (1.7%), respectively. This is in agreement with other
scenarios of surface dose measurements due to higher WED of GAFCHROMIC EBT2 film in
comparison with the MOSkin detector.
The presence of any materials between the radiation source and the phantom or patient will alter
the dose to the build-up region. In this work, constant MU (100 MUs) was given. The presence
of physical wedge under the photon beam will harden the photon beam by absorbing scattered
radiation.(38) The presence of the wedge will also produce low energy scattered radiation.(46)

Fig. 8. Wedges response measurement of Markus ionization chamber, Gafchromic EBT2 film, and MOSkin detector and normalized to 1 at open field. The error bar represents 1 SD of three sets of measurements. The average standard
deviation of three sets of measurements for MOSkin detector, Gafchromic EBT2 film, and Markus ionization chamber
is 0.033, 0.019, and 0.001, respectively.

IV. Conclusions
The surface dose measured with MOSkin detector was investigated on a phantom surface for
different SSD, field sizes, surface dose, oblique beams, machine dose rates, and in the presence
of the wedge in comparison with EBT2 film and Markus ionization chamber.
MOSkin detector showed deviation of less than 2% over a change of 80 – 110 cm SSD. For
field size dependence, they are in agreement with Attix ionization chamber.(29) Surface dose
measured with the MOSkin detectors increases from 0.36 to 2.32 times of the surface dose
measurement at 10 × 10 cm² for the field sizes from 1 × 1 cm² to 40 × 40 cm². The dose difference between the MOSkin detector and Markus ionization chamber was 4.44% and 1.74%
for 6 MV and 10 MV photon beams, respectively. This is due to the different WEDs for both
detectors. The dose gradient in the buildup region of 6 MV photon beam is steeper than that
of the 10 MV photon beam. When oblique beams are used, surface dose measured with the
MOSkin detector increases up to 1.95 times of the normal beam incidence. For angular dependence, MOSkin detector in face-up orientation is in agreement with Attix ionization chamber.(26)
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Maximum deviation of 18.5% was found with face-down orientation. The orientation (face-up
or face-down) of the MOSkin detector must be taken into account when used for skin dose
measurement. The MOSkin measurement is in close agreement with Gafchromic EBT2
film for the measurement made under the presence of wedges.
MOSkin detector is suitable detector for in vivo skin dosimetry as compared to Gafchromic
EBT2 film because of its WED of 0.07 mm. However, due to the difference between the detector’s WED and materials, neither can be used as true benchmarked for determining MOSkin
detector accuracy as skin dosimeter. Monte Carlo calculation may provide a true benchmark
tool for this comparison. However, this is not within the scope of this study.
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